文献速递流行病学与生物统计临床试验与 GCP

N-of-1试验评估老年人药物减停对短期临床结局影响的系统评价

N-of-1 trials for assessing the effects of deprescribing medications on short-term clinical outcomes in older adults: a systematic review.
PubMed 文献 · J Clin Epidemiol · 2017-09-22

本系统评价旨在确定N-of-1方法用于老年人药物减停试验的适用性,纳入6项在≥50岁人群中采用N-of-1试验方法进行少于一年长期治疗减停的研究。四项试验显示治疗获益不显著,其中两项收集随访数据的研究中大量患者停药(N=8/18,9/14[44.4–64.3%]);两项治疗有益的研究中所有参与者在随访时维持方案。作者认为N-of-1试验方法学可用于生成患者特异性证据并辅助处方决策,未来需研究评估其用于确定药物减停对短期结局影响的可行性。

要点

  • 共纳入6项在≥50岁人群中采用N-of-1方法进行药物减停的研究。
  • 四项试验显示治疗获益不显著,两项有随访数据的研究中停药比例为8/18和9/14(44.4–64.3%)。
  • 两项治疗有益的研究中所有参与者在随访时维持方案。

核心结论

  • N-of-1试验方法学可用于生成患者特异性药物证据并辅助处方决策。
  • 未来需研究评估使用N-of-1方法确定药物减停对短期结局影响的可行性。

研究设计与样本

  • 系统评价,纳入在老年人(≥50岁)中采用N-of-1试验方法对任何长期治疗进行少于一年减停的人体研究。
  • 两位作者独立筛选文献并提取数据,按照PRISMA指南进行,使用PEDro量表进行质量评价。

主要发现

  • 共纳入6项研究,试验考察药物和非药物治疗对疾病的疗效。
  • 四项试验显示治疗获益不显著,其中两项收集了随访数据的研究中大量患者停药(N=8/18,9/14[44.4–64.3%])。
  • 两项治疗有益的研究中所有参与者在随访时维持方案。

临床怎么用

  • 作者认为N-of-1试验方法学可用于生成患者特异性药物证据并辅助处方决策。

局限性

  • 未来需研究评估使用N-of-1方法确定药物减停对短期结局影响的可行性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objective of this study was to determine the applicability of utilizing the N-of-1 method for deprescribing trials in older adults. STUDY DESIGN AND SETTING: Systematic review of any human studies conducted in older adults (≥50 years), deprescribing any long-term treatment over less than a year using the N-of-1 trial method was performed. Two authors independently reviewed all articles for eligibility and extracted data. The review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Quality assessment of trials was carried out using the Physiotherapy Evidence Database scale. RESULTS: Six studies were identified and extracted. Trials investigated the efficacy of pharmacological and non-pharmacological therapies for treating diseases. Four trials demonstrated non-significant benefits of treatment, with a significant number of patients discontinuing their medications in two trials where follow-up data was collected (N = 8/18, 9/14 [44.4--64.3%]). In two studies, where treatment was beneficial, all participants were found to be maintaining regimen at follow-up. CONCLUSION: The N-of-1 trial methodology can be used to generate patient-specific evidence of medication and inform prescribing decisions. Future studies are required to assess the feasibility of using the N-of-1 method to determine the effects of deprescribing medications on short-term outcomes.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Clough AJ, Hilmer SN, Naismith SL, et al. N-of-1 trials for assessing the effects of deprescribing medications on short-term clinical outcomes in older adults: a systematic review. J Clin Epidemiol. 2017. PMID: 28951110. doi:10.1016/j.jclinepi.2017.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。